Note 7 - Accounts Receivable |
3 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||
Accounts Receivable [Member] | |||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||
Accounts and Nontrade Receivable [Text Block] |
Note 7. Accounts Receivable
At March 31, 2025 and December 31, 2024, accounts receivable consisted of the following (in thousands):
The company revises its estimate of expected credit losses each reporting period based on current economic conditions and reasonable and supportable forecasts and, as a result, the allowance for credit losses was decreased by $78,000 for the three months ended March 31, 2025.
Accounts receivable – trade, net for the Company as of January 1, 2024 and March 31, 2024 were approximately $8.9 million and $12.9 million, respectively. |
X | ||||||||||
- Definition The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|